We therefore aimed to investigate how AMPK modulates adipokine production triggered by obesity- and type 2 diabetes mellitus (T2DM)-related factors and how such a modulation may prevent insulin resistance and breast tumour cell proliferation. Here, PRKAA1 is linked to Insulin resistance.